ALLYX THERAPEUTICS Trademark

Trademark Overview

On Thursday, February 24, 2022, a trademark application was filed for ALLYX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALLYX THERAPEUTICS trademark a serial number of 97282621. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Allyx Therapeutics, Inc.. The ALLYX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia
allyx therapeutics

General Information

Serial Number97282621
Word MarkALLYX THERAPEUTICS
Filing DateThursday, February 24, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllyx Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06513
Party NameAllyx Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Haven, CT 06513

Trademark Events

Event DateEvent Description
Monday, February 28, 2022NEW APPLICATION ENTERED
Wednesday, March 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 8, 2022ASSIGNED TO EXAMINER
Wednesday, December 14, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 14, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, December 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 14, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, December 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 10, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, March 31, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, April 17, 2023ASSIGNED TO PETITION STAFF
Tuesday, April 18, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, May 28, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, January 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED
Thursday, October 31, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 GRANTED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2024SOU EXTENSION 1 FILED

Related Keywords

therapeutics allyx treatment including products hemophilia diseases neurodegenerative preparations prevention pharmaceutical